NDC 0061-1438-02 - Bravecto Quantum
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-1438
- Requested NDC
- 0061-1438-02
- Package NDCs from labels
- 0061-1438-02
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BRAVECTO ® QUANTUM (fluralaner for extended-release injectable suspension) | Merck Sharp & Dohme Corp. | 2026-08-03 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-1438-02 | Bravecto Quantum | 1 in 1 CARTON | KIT | 1 | 2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.